Skip to content
Screener

Shares (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
371M-1.9%
Danaher logo
DanaherDHR
707.6M-1.6%
Azenta logo
AzentaAZTA
45.3M-1.1%
Agilent Technologies logo
Agilent TechnologiesA
283M-0.7%
Illumina logo
IlluminaILMN
153M-2.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
305.6M+2.4%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands, except per share data)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Net loss, basic and diluted$(44,021)$(39,328)$(74,528)$(70,922)
Weighted average shares used in computing net loss per share, basic and diluted61,70259,64961,38759,403
Net loss per share, basic and diluted$(0.71)$(0.66)$(1.21)$(1.19)

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's shares (diluted)?
Twist Bioscience Corporation (TWST) reported shares (diluted) of 61.7M in Q1 2026.
How has Twist Bioscience Corporation's shares (diluted) changed year-over-year?
Twist Bioscience Corporation's shares (diluted) increased by 3.4% year-over-year, from 59.6M to 61.7M.
What is the long-term trend for Twist Bioscience Corporation's shares (diluted)?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's shares (diluted) has grown at a 5.7% compound annual growth rate (CAGR), from 191.9M to 239.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Twist Bioscience Corporation's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude